Characteristics of Included Studies | Medication Time | Doses of Medication | Number of Patients | ||||||
Study | Year | N | Clinical Trail Setting | Fondaparinux | LMWH | Fondaparinux | LMWH | Fondaparinux | LMWH |
OASIS-5 | 2006 | 20078 | Multicentered, double blind RCT | 8 Day | 2 - 8 Day | 2.5 mg qd | 1 mg/kg bid | 10021 | 10057 |
PENTUA | 2004 | 459 | Multicentered, double blind RCT | 3 - 7 Day | 3 - 7 Day | 2.5 mg qd | 1 mg/kg bid | 229 | 230 |
Yan | 2011 | 300 | prospective, open-label, and single center study, RCT | 4 Day | 4 Day | 2.5 mg qd | 0.01 ml/kg q12 | 150 | 150 |